Objective: The aim was to provide guidelines for evaluation, treatment, and genetic testing
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …

Multiple endocrine neoplasia (MEN) is characterized by the occurrence of tumors involving
two or more endocrine glands within a single patient. Four major forms of MEN, which are …

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder
characterized by the occurrence of tumors of the parathyroids, pancreas, and anterior …

Abstract Prolactin-secreting tumors (prolactinomas), the most frequently occurring pituitary
tumor, have a frequency that varies with age and sex. They occur most frequently in females …

Multiple endocrine neoplasia type 1 (MEN1) consists of benign, and sometimes malignant,
tumors (often multiple in a tissue) of the parathyroids, enteropancreatic neuroendocrine …

Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal-dominant disorder
characterised by the occurrence of tumours of the parathyroids, pancreas and anterior …

According to data derived from autopsy and radiological imaging series, pituitary tumours
occur very commonly in the general population; however, most of these tumours are …

Recent data suggest an increase in the overall incidence of parathyroid disorders, with
primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is …

Multiple endocrine neoplasia type 1 (MEN1) provides a prime example of how a rare
disease can advance our understanding of basic cell biology, neoplasia and common …

BACKGROUND Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal‐dominant
syndrome associated with neoplasia of pituitary, pancreas, parathyroid, and foregut lineage …